- Eli Lilly raised Zepbound prices in the U.K. and plans to follow price hikes across Europe, while Novo Nordisk received a drug price reduction letter amid Trump administration pressure.
- The FDA has ruled on copycat drugs produced in China, while Novo Nordisk navigates price reduction demands from Trump and leadership changes.
- Trump administration announced FDA coverage changes regarding Chinese suppliers who are not registered.
- The Trump administration is leading to FDA job cuts, while Elon Musk spearheaded the Department of Government Efficiency, and China has surpassed the US in clinical trial volume.
Trump administration proposes new approaches to stretch FDA resources, involving Michael Rogers.
1 report, 1 independent
Updated Sep 8
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Trump administration proposes new approaches to stretch FDA resources, involving Michael Rogers.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)